Top Markets
Coin of the day
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Peringkat dalam Saham #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Harga Saham
$0.07600875
Terakhir disinkronkan: 2024-11-20
Kapitalisasi Pasar
$2.06M
Perubahan (1 hari)
-0.51%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Quantum Genomics S.A. (ALQGC)

Kategori

Rasio P/S untuk Quantum Genomics S.A. (ALQGC)
Rasio P/S per August 2026 TTM: 499.95K
Menurut laporan keuangan dan harga saham terbaru dari Quantum Genomics S.A., rasio P/S saat ini (TTM) adalah 499.95K. Pada akhir 2023, rasio P/S perusahaan adalah 186.65.
Riwayat rasio P/S untuk Quantum Genomics S.A. dari 2009 hingga 2026
Rasio P/S pada akhir setiap tahun
Tahun Rasio P/S Mengubah
2026 (TTM) 499.95K -0.53%
2024 502.59K 269,175.26%
2023 186.65 11,422.08%
2022 1.62 -95.60%
2021 36.83 -32.65%
2020 54.68 39.21%
2019 39.28 -99.83%
2018 22.77K 0.00%
2017 0.00 0.00%
2016 0.00 -100.00%
2015 406.74 397.85%
2014 81.70 -94.18%
2013 1.40K 15.20%
2012 1.22K 290.81%
2011 311.74 0.00%
2010 311.74 -14.29%
2009 363.69 0.00%
Rasio P/S untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/S Perbedaan Rasio P/S Negara
10.17 -100.00%
US
10.13 -100.00%
NL
- -
CH
- -
KR
4.74 -100.00%
BE